Honokiol
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Honokiol
Description :
Honokiol is a bioactive, biphenolic phytochemical that possesses potent antioxidative, anti-inflammatory, antiangiogenic, and anticancer activities by targeting a variety of signaling molecules. It inhibits the activation of Akt. Honokiol can readily cross the blood brain barrier[1][2][3][4].Product Name Alternative :
NSC 293100UNSPSC :
12352005Hazard Statement :
H318, H410Target :
Akt; Autophagy; ERK; HCVType :
Natural ProductsRelated Pathways :
Anti-infection; Autophagy; MAPK/ERK Pathway; PI3K/Akt/mTOR; Stem Cell/WntApplications :
Cancer-Kinase/proteaseField of Research :
CancerAssay Protocol :
https://www.medchemexpress.com/honokiol.htmlPurity :
99.94Solubility :
DMSO : ≥ 50 mg/mLSmiles :
OC1=C(CC=C)C=C(C2=CC(CC=C)=CC=C2O)C=C1Molecular Formula :
C18H18O2Molecular Weight :
266.33Precautions :
H318, H410References & Citations :
[1]Chang KH, et al. Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells. Oncol Lett. 2013 Nov;6 (5) :1435-1438.|[2]Godugu C, et al. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC) . Colloids Surf B Biointerfaces. 2017 Jan 23;153:208-219|[3]Lee TY, et al. Honokiol as a specific collagen receptor glycoprotein VI antagonist on human platelets: Functional ex vivo and in vivo studies. Sci Rep. 2017 Jan 5;7:40002|[4]Zhai H, et al. Honokiol-induced neurite outgrowth promotion depends on activation of extracellular signal-regulated kinases (ERK1/2) . Eur J Pharmacol. 2005 Jun 1;516 (2) :112-7.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Natural ProductsClinical Information :
Phase 3Isoform :
ERK1; ERK2CAS Number :
[35354-74-6]

